Cargando…

Cognitive Function: Is There More to Anticoagulation in Atrial Fibrillation Than Stroke?

Detalles Bibliográficos
Autores principales:	Cao, Lin, Pokorney, Sean D, Hayden, Kathleen, Welsh-Bohmer, Kathleen, Newby, L Kristin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2015
Materias:	Contemporary Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599450/ https://www.ncbi.nlm.nih.gov/pubmed/26240065 http://dx.doi.org/10.1161/JAHA.114.001573

Ejemplares similares

Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions
por: Di Biase, Luigi
Publicado: (2016)

An Updated Review of Target‐Specific Oral Anticoagulants Used in Stroke Prevention in Atrial Fibrillation, Venous Thromboembolic Disease, and Acute Coronary Syndromes
por: Cove, Christina L., et al.
Publicado: (2013)

Left Atrial Appendage Occlusion for Stroke Prevention in Nonvalvular Atrial Fibrillation
por: Collado, Fareed Moses S., et al.
Publicado: (2021)

Secondary Stroke Prevention Following Embolic Stroke of Unknown Source in the Absence of Documented Atrial Fibrillation: A Clinical Review
por: Kotadia, Irum D., et al.
Publicado: (2021)

Role of Monocytes in Heart Failure and Atrial Fibrillation
por: Shahid, Farhan, et al.
Publicado: (2018)

Contemporary Management of Atrial Fibrillation: What Can Clinical Registries Tell Us About Stroke Prevention and Current Therapeutic Approaches?
por: Lip, Gregory Y. H., et al.
Publicado: (2014)

Characterization, Pathogenesis, and Clinical Implications of Inflammation‐Related Atrial Myopathy as an Important Cause of Atrial Fibrillation
por: Packer, Milton
Publicado: (2020)

Exploring Refractoriness as an Adjunctive Electrical Biomarker for Staging of Atrial Fibrillation
por: van Staveren, Lianne N., et al.
Publicado: (2020)

Guidance on Short‐Term Management of Atrial Fibrillation in Coronavirus Disease 2019
por: Rattanawong, Pattara, et al.
Publicado: (2020)

Residual stroke risk despite oral anticoagulation in patients with atrial fibrillation
por: Carlisle, Matthew A., et al.
Publicado: (2022)

High‐Sensitivity Troponin Assays: Evidence, Indications, and Reasonable Use
por: Sherwood, Matthew W., et al.
Publicado: (2014)

Studies on Atrial Fibrillation and Venous Thromboembolism in the Past 20 Years: A Bibliometric Analysis Via CiteSpace and VOSviewer
por: Miao, Lina, et al.
Publicado: (2023)

Potential Role of Atrial Myopathy in the Pathogenesis of Stroke in Rheumatoid Arthritis and Psoriasis: A Conceptual Framework and Implications for Prophylaxis
por: Packer, Milton
Publicado: (2020)

Evidence Gaps in the Era of Non–Vitamin K Oral Anticoagulants
por: Aronis, Konstantinos N., et al.
Publicado: (2018)

Risks of anticoagulation in patients with chronic kidney disease and atrial fibrillation: More than just bleeding?
por: Gutiérrez, Orlando M.
Publicado: (2019)

Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges
por: Chen, Ashley, et al.
Publicado: (2020)

Cost Analysis of a Managed Care Decentralized Outpatient Pharmacy Anticoagulation Service
por: Anderson, Robert
Publicado: (2004)

More, More, More: Reducing Thrombosis in Acute Coronary Syndromes Beyond Dual Antiplatelet Therapy—Current Data and Future Directions
por: Spinthakis, Nikolaos, et al.
Publicado: (2018)

Use of Direct Oral Anticoagulants Among Patients Undergoing Cardioversion: The Importance of Timing Before Cardioversion
por: Warden, Bruce A., et al.
Publicado: (2018)

High prevalence of atrial fibrillation among Greenlanders with ischemic stroke – atrial fibrillation found in more than 30% of cases
por: Bjorn-Mortensen, Karen, et al.
Publicado: (2013)

Pregnancy Complicated by Valvular Heart Disease: An Update
por: Nanna, Michael, et al.
Publicado: (2014)

Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
por: Turpie, Alexander GG
Publicado: (2014)

Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
por: Schäfer, Andreas, et al.
Publicado: (2020)

Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation
por: Meinel, Thomas R., et al.
Publicado: (2020)

Atrial Fibrillation and Ischemic Stroke despite Oral Anticoagulation
por: Galea, Roberto, et al.
Publicado: (2023)

Atrial fibrillation, electroconvulsive therapy, stroke risk, and anticoagulation
por: Kapadia, Meera, et al.
Publicado: (2023)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

Evidence That a Subset of Aneurysms Less Than 7 mm Warrant Treatment
por: Zanaty, Mario, et al.
Publicado: (2016)

Anticoagulant use for the prevention of stroke in patients with atrial fibrillation: findings from a multi-payer analysis
por: Lang, Kathleen, et al.
Publicado: (2014)

Etiology of Ischemic Strokes of Patients with Atrial Fibrillation and Therapy with Anticoagulants
por: Purrucker, Jan C., et al.
Publicado: (2020)

Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke
por: García Rodríguez, Luis Alberto, et al.
Publicado: (2021)

Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
por: Tiili, Paula, et al.
Publicado: (2021)

Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation
por: Polymeris, Alexandros A., et al.
Publicado: (2021)

Stroke–Heart Syndrome: Recent Advances and Challenges
por: Scheitz, Jan F., et al.
Publicado: (2022)

Maternal Heart Failure
por: Bright, Rachel A., et al.
Publicado: (2021)

Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation
por: O'Neal, Wesley T., et al.
Publicado: (2018)

Combining Intravenous Thrombolysis and Antithrombotic Agents in Stroke: An Update
por: Derex, Laurent, et al.
Publicado: (2018)

Oral anticoagulant decreases stroke recurrence in patients with atrial fibrillation detected after stroke
por: Hsu, Jin-Yi, et al.
Publicado: (2022)

Cognitive function and adherence to anticoagulation treatment in patients with atrial fibrillation
por: Jankowska-Polańska, Beata, et al.
Publicado: (2016)

Patent Foramen Ovale Closure for Stroke Prevention and Other Disorders
por: Collado, Fareed Moses S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q15o72r01bijtd3n8tt1otbm3u